君实生物：第三季度归母净亏损1.83亿元

Core Insights - The company reported a revenue of 637 million yuan for Q3 2025, representing a year-on-year growth of 31.40% [1] - The net loss attributable to shareholders for the same quarter was 183 million yuan, with a basic earnings per share of -0.18 yuan [1] - For the first three quarters of 2025, the company achieved a total revenue of 1.806 billion yuan, marking a year-on-year increase of 42.06% [1] - The net loss attributable to shareholders for the first three quarters was 596 million yuan, with a basic earnings per share of -0.6 yuan [1]